AIN and GN: When Tissue Changes the Decision

Clinical Mastery · Visual teaching summary · October 3, 2026

Andrew Bland, MD, FACP, FAAP

Visual summary

Histology, immunofluorescence, electron microscopy, clinical context, and the trajectory should tell a coherent story. A biopsy pattern still needs an etiologic explanation.

AIN and GN: When Tissue Changes the Decision: six-panel learning summary. Full text follows below.
Download infographic (PNG) · Download Markdown · Read text version ·

Text version

Different compartments

Interstitial inflammation and glomerular inflammation can both cause AKI, but their causes, urine patterns, and treatment pathways differ. Mixed injury is possible.

Look for supporting clues

Medication timing, systemic symptoms, proteinuria, hematuria, and sediment findings guide suspicion. The classic allergic triad is often absent in AIN.

Avoid weak rule-out tests

Urine eosinophils have limited diagnostic performance. Serologies and urine microscopy can support a hypothesis, but none replaces clinical reasoning or automatically establishes pathology.

Use biopsy purposefully

Consider tissue when uncertainty affects immunosuppression, prognosis, or another major decision. Evaluate bleeding risk and whether the result will change care.

Address the cause

Stop plausible offending drugs and investigate infection or systemic disease. Immunosuppression decisions require diagnosis, timing, chronicity, and patient-specific risk assessment.

Interpret the whole specimen

Histology, immunofluorescence, electron microscopy, clinical context, and the trajectory should tell a coherent story. A biopsy pattern still needs an etiologic explanation.

Continue learning

This graphic summarizes a topic. The full educational pages provide the broader discussion and references.